MFN2 and amyotrophic lateral sclerosis: Russell et al. (Russell et al., 2013) showed that twenty-one distinct mutations in MFN2 identified in sporadic ALS patients render the protein defective in rescuing morphological defects in MFN2 knockout mouse embryonic fibroblasts (MEFs).